R&D expenses of selected Chinese pharma companies 2021
one to ten percent of their sales revenue in research and development. That year, Changchun High & New Technology Industries Group spent around 1.1 billion yuan on R&D, followed by Livzon Pharmaceutical Group with 990 million yuan.
In 2021, the Chinese pharmaceutical companies invested between